A rumor in favor of Gulen is widely circulated in the market. It is rumored that a large institution, including large and medium-sized insurance funds, investment managers and FOF special deposit accounts, recently redeemed the market share of China Europe Star Fund Director Gu Lun, and was redeemed by nearly 40 billion RMB, because it rationally laid out a number of new energy technologies such as Ganfeng Lithium Industry at a low level. Several all-field funds she managed bought 70% of new energy technologies.
Regarding this matter, the relevant person in charge of China Europe Fund told the reporter of 2 1 New Century Economic Development Report that the "super-large redemption" that exploded on the Internet was false information, so don't listen to rumors.
In view of Glenn being listed on the hot search list by netizens because of the plummeting of the Department of Pharmacy, V Danbin, the investment boss of China Oriental Harbor Project and a famous private equity investor, said on my social media that it is very easy for everyone to have their own opinions and resolutions on project investment, but it is not easy to stick to what they think is appropriate. It's easy in a good situation and difficult in a bad process, which is why it's particularly difficult.
The physical and mental health of China Europe International Business School, the largest operation, has already fallen below the end of last year. This also means that many people who joined the fund last year have suffered losses so far.
As a result, investors went crazy. For this matter, some professionals said that under the trend of overall adjustment of the medical industry, the fund industry adopting the Gulen management method cannot live up to its heart. In addition, due to the concentration of medical theme-style funds and heavy stocks, the stock price changes of heavy stocks are also harmful to the fund as a whole.
In view of the practical operation ideas, Gulen said in the fourth quarterly report that the overall operation was maintained at a high level, mainly to achieve a reasonable layout in the entire industrial chain such as innovative drugs, health services, and high-quality new drug industry leaders.
From the perspective of future equipment positioning, Gulen emphasized that the whole industrial chain of innovative drugs is still her long-term positioning. From the cultural construction of current policies in China to the accumulation of independent innovation of China companies in recent years, the whole industrial chain of independent innovation and drug production in China has remained in a state of high depression for a long time.